Literature DB >> 9779627

Laparoscopic evaluation in pancreatic cancer.

N B Merchant1, K C Conlon.   

Abstract

Pancreatic cancer continues to carry a poor overall prognosis. The majority of patients have advanced disease at the time of presentation. Dynamic, contrast-enhanced computed tomography (CT) has become the radiographic study of choice in the pre-operative staging of patients with pancreatic cancer. While it has been shown to be highly sensitive in determining unresectability of peri-ampullary tumors, the ability of CT to predict accurately which tumors can be safely resected is still limited. Laparoscopic staging of peri-ampullary tumors is superior to dynamic CT in visualizing small liver and peritoneal metastases. The addition of laparoscopic ultrasound during laparoscopic staging enhances the ability of laparoscopy to determine resectability of these tumors and approaches the accuracy of open exploration without increasing significant morbidity or mortality. Patients who are deemed unresectable at the time of laparoscopy can undergo palliative biliary and/or gastric bypass procedures laparoscopically and further minimize the morbidity of laparotomy.

Entities:  

Mesh:

Year:  1998        PMID: 9779627     DOI: 10.1002/(sici)1098-2388(199810/11)15:3<155::aid-ssu4>3.0.co;2-a

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  9 in total

1.  The impact of laparoscopic biopsy of pancreatic lymph nodes with helium and carbon dioxide on port site and liver metastasis in BOP-induced pancreatic cancer in hamster.

Authors:  F A Wenger; C A Jacobi; M Kilian; H Dressler; H Guski; J M Müller
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 2.  Vascular invasion in pancreatic cancer: Imaging modalities, preoperative diagnosis and surgical management.

Authors:  Nicolas C Buchs; Michael Chilcott; Pierre-Alexandre Poletti; Leo H Buhler; Philippe Morel
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742

3.  Diagnostic laparoscopy for periampullary and pancreatic cancer: what is the true benefit?

Authors:  Christopher J Barreiro; Keith D Lillemoe; Leonidas G Koniaris; Taylor A Sohn; Charles J Yeo; JoAnn Coleman; Elliot K Fishman; John L Cameron
Journal:  J Gastrointest Surg       Date:  2002 Jan-Feb       Impact factor: 3.452

4.  Diagnostic Laparoscopy Prior to Neoadjuvant Therapy in Pancreatic Cancer Is High Yield: an Analysis of Outcomes and Costs.

Authors:  June S Peng; Jeffrey Mino; Rosebel Monteiro; Gareth Morris-Stiff; Noaman S Ali; Jane Wey; Kevin M El-Hayek; R Matthew Walsh; Sricharan Chalikonda
Journal:  J Gastrointest Surg       Date:  2017-06-08       Impact factor: 3.452

5.  The value of laparoscopy in the management of ampullary, duodenal, and distal bile duct tumors.

Authors:  Ari D Brooks; Michael J Mallis; Murray F Brennan; Kevin C P Conlon
Journal:  J Gastrointest Surg       Date:  2002 Mar-Apr       Impact factor: 3.452

Review 6.  Pancreatic cancer: can we screen? How should we stage?

Authors:  A A Parikh; A M Lowy
Journal:  Curr Gastroenterol Rep       Date:  1999-04

7.  Impact of taurolidin and octreotide on liver metastasis and lipid peroxidation after laparoscopy in chemical induced ductal pancreatic cancer.

Authors:  Maik Kilian; Jan Ilga Gregor; Ina Heukamp; Chris Braumann; Hans Guski; Ingolf Schimke; Martin Karl Walz; Christoph Andreas Jacobi; Frank Axel Wenger
Journal:  Invest New Drugs       Date:  2005-03       Impact factor: 3.850

Review 8.  Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.

Authors:  Victoria B Allen; Kurinchi Selvan Gurusamy; Yemisi Takwoingi; Amun Kalia; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2016-07-06

9.  Place of hyperthermic intraperitoneal chemotherapy in the armament against pancreatic adenocarcinoma: A survival, mortality and morbidity systematic review.

Authors:  Andreas Larentzakis; Evangelos Anagnostou; Konstantinos Georgiou; Gavriella-Zoi Vrakopoulou; Constantinos G Zografos; Georgios C Zografos; Konstantinos G Toutouzas
Journal:  Oncol Lett       Date:  2021-02-03       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.